ASX - Delayed Quote
AUD
Vitrafy Life Sciences Limited (VFY.AX)
2.4500
0.0000
(0.00%)
As of November 9 at 10:06:33 AM GMT+11. Market Open.
Loading chart for VFY.AX
- Previous Close
2.4500 - Open
2.4500 - Bid 2.4500 x --
- Ask 2.4800 x --
- Day's Range
2.4500 - 2.4500 - 52 Week Range
1.2800 - 4.6600 - Volume
4,439 - Avg. Volume
57,553 - Market Cap (intraday)
186.804M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2500 - Earnings Date --
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
5.08 - Moby Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
VFY.AX
91.41%
S&P/ASX 200 [XJO] (^AXJO)
3.01%
1-Year Return
VFY.AX
66.67%
S&P/ASX 200 [XJO] (^AXJO)
1.65%
3-Year Return
VFY.AX
22.50%
S&P/ASX 200 [XJO] (^AXJO)
28.67%
5-Year Return
VFY.AX
22.50%
S&P/ASX 200 [XJO] (^AXJO)
20.91%
Analyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-27.94%
-
Return on Equity (ttm)
-46.29%
-
Revenue (ttm)
209k
-
Net Income Avi to Common (ttm)
-16.17M
-
Diluted EPS (ttm)
-0.2500
Balance Sheet and Cash Flow
-
Total Cash (mrq)
41.22M
-
Total Debt/Equity (mrq)
0.74%
-
Levered Free Cash Flow (ttm)
-10.84M
